GlassScriptPhysician profile
Linquan Sun
NPI 1619286994
$2,930.23
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,549 · 2020: $257 · 2021: $125.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $584.87 | 2019-2020 | |
| Genentech USA, INC. | $324.44 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $219.96 | 2019 | |
| Genzyme Corporation | $217.28 | 2019 | |
| Biogen, INC. | $212.71 | 2019 | |
| Emd Serono, INC. | $202.67 | 2019 | |
| Amgen INC. | $191.48 | 2019 | |
| Novartis Pharmaceuticals Corporation | $168.63 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $155.69 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $151.62 | 2019 | |
| Allergan, INC. | $125.46 | 2019-2020 | |
| Celgene Corporation | $125.00 | 2019 | |
| Acorda Therapeutics, INC | $48.93 | 2019 | |
| Assertio Therapeutics, INC. | $32.45 | 2019 | |
| Jazz Pharmaceuticals INC. | $28.66 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $27.96 | 2019 | |
| Neurocrine Biosciences, INC. | $26.82 | 2019 | |
| Bausch Health US, LLC | $22.11 | 2019 | |
| Ucb, INC. | $21.68 | 2019 | |
| Lundbeck LLC | $15.99 | 2019 | |
| Mdd US Operations, LLC | $14.18 | 2019 | |
| Acadia Pharmaceuticals INC | $11.64 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linquan Sun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.